Lee Danner & Bass Inc. Decreases Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Lee Danner & Bass Inc. trimmed its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 22.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,687 shares of the real estate investment trust's stock after selling 14,691 shares during the period. Lee Danner & Bass Inc.'s holdings in Healthpeak Properties were worth $1,027,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Harvest Fund Management Co. Ltd bought a new stake in Healthpeak Properties in the fourth quarter valued at $30,000. Avior Wealth Management LLC bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $37,000. Wiser Advisor Group LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at about $42,000. Continuum Advisory LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at about $44,000. Finally, AdvisorNet Financial Inc raised its stake in Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock worth $44,000 after buying an additional 563 shares in the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on DOC. StockNews.com raised Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Saturday. Wells Fargo & Company dropped their price target on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 10th. Wedbush decreased their price objective on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, February 14th. Mizuho dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Finally, Robert W. Baird reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research report on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Healthpeak Properties presently has an average rating of "Moderate Buy" and a consensus target price of $23.92.

Remove Ads

Healthpeak Properties Stock Up 0.8 %

Healthpeak Properties stock traded up $0.16 during trading hours on Wednesday, hitting $20.32. The stock had a trading volume of 3,661,246 shares, compared to its average volume of 4,624,604. The stock's 50-day moving average price is $20.25 and its 200-day moving average price is $21.14. The stock has a market capitalization of $14.21 billion, a P/E ratio of 58.04, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 12-month low of $17.51 and a 12-month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a $0.305 dividend. This is a positive change from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 6.01%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties's payout ratio is presently 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.